juvena-logo
juvena-logo

News

Podcasts


November, 2024

CEO Dr. Hanadie Yousef discusses Juvena’s AI-enabled platform for mapping the therapeutic potential of stem cell secreted proteins and engineering restorative biologics for age-related and chronic diseases on the podcast Impact AIListen Now »


April, 2024

One of In Vivo’s 2024 Rising Leaders, Dr. Hanadie Yousef, CEO of Juvena Therapeutics, talks about the secretome as a source of therapeutics, the company’s lead assets, the future of longevity medicine and learning as you go as a biotech entrepreneur.Listen Now »


June, 2023

Discovery of Biologic Therapeutics in the AI/ML Era: 20-year industry veteran and Vice President of Data Science, Dr. Edward Moler, PhD, shares his insights on navigating AI-driven discoveries with high therapeutic potentialListen Now »


May, 2023

Check out the Pharma Exec Podcast of CEO Dr. Hanadie Yousef’s interview for the Emerging Pharma Leader award to learn more about what drives her ambitions for JuvenaListen Now »


January, 2023

Juvena’s Head of Data Science, Dr. Eddie Moler interviewed about his experiences in data science and AI applied to diagnostics and drug discovery and shares why he is excited about JuvenaListen Now »


CEO-Dr.-Hanadie-Yousef-Interviewed-for-Translating-Aging-PodcastThe-Cures-Within-Us-thumb

August, 2021

CEO Dr. Hanadie Yousef Interviewed for Translating Aging Podcast, “The Cures Within Us”Listen Now »


juvena-logo-wht

Navigation

  • Home
  • Platform
  • Disease Indications
  • Pipeline
  • Team
  • Join Us
  • News
  • Contact Us
  • Home
  • Platform
  • Disease Indications
  • Pipeline
  • Team
  • Join Us
  • News
  • Contact Us

Contact

640 Galveston Drive
Redwood City, CA 94063
Get Directions »
650.223.5879
info@juvenatherapeutics.com

Stay in touch

Subscribe to our newsletter

By entering your email you agree to our Privacy Policy

© 2023 Juvena Therapeutics Inc. All Rights Reserved | Privacy Policy

  • Home
  • Platform
  • Disease Indications
  • Pipeline
  • Team
  • Join Us
  • News
  • Contact Us
  • Home
  • Platform
  • Disease Indications
  • Pipeline
  • Team
  • Join Us
  • News
  • Contact Us